Valverde, O <br/><br/>
Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats.  [electronic resource] 

 -  Neuroscience letters  Mar 1998 
 - 37-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0304-3940 
<br/><br/><label>Standard No.: </label>10.1016/s0304-3940(98)00118-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Anxiety Agents--pharmacology<br/>Avoidance Learning--drug effects<br/>Benzodiazepinones--pharmacology<br/>Cholecystokinin--analogs & derivatives<br/>Conditioning, Classical--drug effects<br/>Devazepide<br/>Indoles--pharmacology<br/>Male<br/>Meglumine--analogs & derivatives<br/>Morphine Dependence--physiopathology<br/>Peptide Fragments--pharmacology<br/>Phenylurea Compounds<br/>Rats<br/>Rats, Wistar<br/>Substance Withdrawal Syndrome--physiopathology